ArticleOncotarget2023

Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin.

Carsten Springer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.